The Intersection of Pass-Through Entities and the Massachusetts Research and Development Tax Credit: A Comprehensive Legal and Regulatory Analysis

Pass-through entities within the framework of the Massachusetts Research and Development tax credit are business structures, such as partnerships and limited liability companies, that attribute qualified research expenses and receipts directly to their owners for credit calculation purposes. Unlike traditional corporations, these entities serve as conduits, allowing the tax benefits of innovation to manifest on the individual or corporate partner’s tax return rather than at the entity level, with the notable exception of S-corporations which utilize the credit against their own excise.1

The legal architecture of the Massachusetts research credit is a sophisticated mechanism established under Massachusetts General Laws (M.G.L.) Chapter 63, Section 38M. This statute provides a robust incentive for businesses to invest in high-technology and scientific advancement within the borders of the Commonwealth. While the credit is fundamentally rooted in the corporate excise tax code, its interaction with pass-through entities (PTEs) creates a complex web of regulatory requirements that span both the corporate excise (Chapter 63) and the personal income tax (Chapter 62) regimes.3 The Department of Revenue (DOR) provides extensive guidance through regulations such as 830 CMR 63.38M.1, which clarifies that for most unincorporated entities, the credit is not a single value passed to owners, but a set of allocated data points—wages, supply costs, and contract expenses—that the owners must then aggregate with their own activities to determine a final credit amount.2 This distinction is critical for tax planning, as the specific classification of the PTE—whether a partnership, a multi-member LLC, or an S-corporation—determines whether the credit remains “trapped” at the entity level or flows through to provide relief to individual stakeholders.1

Historical Evolution and the “Frozen” Federal Conformity

The Massachusetts research credit, while mirroring the federal credit under Internal Revenue Code (IRC) Section 41, operates under a unique principle of “frozen” conformity. The primary calculation methods and definitions are tied to the federal code as it existed on August 12, 1991.3 This historical anchor ensures that the state maintains a consistent tax policy regardless of volatile changes in federal legislation, although it necessitates that taxpayers maintain two separate sets of R&D records: one for the modern federal credit and one for the vintage Massachusetts requirements.8

The legislative intent behind Section 38M was to establish Massachusetts as a premier hub for the life sciences, software development, and manufacturing sectors. By rewarding incremental spending—defined as research expenditures exceeding a historical base amount—the Commonwealth encourages companies to not only sustain but also expand their research footprints.10 For pass-through entities, this means that the historical base amount must be tracked with the same rigor as current-year expenses, as the “moving” nature of the credit requires a rolling analysis of spending patterns over several prior years.1

The Role of Technical Information Releases (TIRs)

The Department of Revenue frequently utilizes Technical Information Releases (TIRs) to provide real-time updates to the application of Section 38M. For example, TIR 14-16 was instrumental in explaining the technical corrections made to the research credit, particularly the introduction of the Alternative Simplified Method (ASM) and the phased-in credit rates that occurred between 2015 and 2021.5 These releases serve as the bridge between the rigid statutory language and the practical realities of corporate and personal income tax filing. For PTEs, these documents clarify how owners should report their distributive shares and how to navigate the complex limitations imposed on the amount of credit that can be claimed in a single tax year.5

Defining Qualified Research in the Commonwealth

To claim the Massachusetts research credit, a pass-through entity must ensure that its activities meet the stringent “Four-Part Test” derived from the IRC. Because Massachusetts largely conforms to federal definitions, the burden of proof for a partnership or LLC remains identical to that of a C-corporation, yet the consequences of an audit are felt directly by the individual partners who claim the credit on their personal returns.8

The Four-Part Test Framework

In the context of Massachusetts, there is an additional, non-negotiable requirement: the research must be conducted physically within the state. This “geographic nexus” means that even if a partnership is headquartered in Boston, any research performed by remote employees or contractors working outside of Massachusetts is strictly excluded from the credit calculation.5

Taxonomy of Qualified Research Expenses (QREs)

The Massachusetts research credit is based on specific types of expenditures, known as Qualified Research Expenses (QREs). For pass-through entities, these expenses are recorded at the entity level and then distributed via Schedule K-1 to the partners.1

Qualified Wage Expenses

Wages paid to employees are often the largest component of the credit. These include the salaries of researchers, as well as those providing “direct supervision” or “direct support” of the research.1 For a partnership, these wages are attributed to the partners based on their distributive share of the entity’s income or loss.3 It is important to note that only the portion of the wage relating to time spent in Massachusetts qualifies.

Supplies and Tangible Property

The cost of supplies used in the conduct of qualified research—such as chemicals, prototype materials, and laboratory equipment that does not qualify for depreciation—can be included.5 For pass-through entities engaged in biotechnology or manufacturing, these supply costs can be substantial. The DOR requires that these supplies be “used or consumed” within Massachusetts to be eligible.5

Contract Research Expenses

If a pass-through entity hires a third party to conduct research on its behalf, it may include 65% of the amounts paid as QREs.8 However, the research must still be performed in Massachusetts. If a Cambridge-based startup hires a lab in California to perform a test, those expenses are disqualified for the Massachusetts credit, even if they qualify for the federal credit.12

Computer Time and Rental

Expenses incurred for the right to use computers to conduct research, such as cloud computing services or server rentals, are qualifying expenses to the extent they are utilized for Massachusetts-based research activities.14 As software-as-a-service (SaaS) and cloud-based R&D become more prevalent, this category is seeing increased scrutiny from the DOR regarding the physical location of the servers versus the users.

The Dual Calculation Methodologies

Massachusetts provides two primary ways to calculate the R&D credit. A pass-through entity does not make this election; rather, the individual partner or corporate owner makes the election on their own return using the data provided by the PTE.3

The Regular Method (Section 38M(a))

The regular method is designed for companies with a long history of R&D spending and stable gross receipts. The credit is equal to 10% of the amount by which current-year Massachusetts QREs exceed a “base amount”.1 The base amount is calculated by multiplying the taxpayer’s average annual gross receipts for the previous four years by a “fixed-base ratio”.15 For pass-through entities, the partnership must provide the gross receipts data for the previous four years to each partner to allow them to perform this calculation.2

The fixed-base ratio is determined by taking the total QREs for the third and fourth years preceding the credit year and dividing them by the total gross receipts for those same two years, capped at 16%.13

The Alternative Simplified Method (ASM) (Section 38M(b))

The ASM is often more favorable for startups or entities with fluctuating expenses because it does not require historical gross receipts data. Instead, the base is simply 50% of the average QREs for the three preceding years.1

The rate for the ASM has been increased significantly over time to match the regular method’s 10% rate.

If the taxpayer did not have QREs in any one of the three preceding years, the ASM credit is capped at 5% of current-year QREs.8 Once an owner elects the ASM, they generally must continue to use it for subsequent years unless they obtain permission from the Commissioner to switch.1

Statutory Limitations and Liability Caps

Even a high-value R&D credit is subject to “use” limitations. Massachusetts law prevents a taxpayer from using the research credit to completely eliminate their tax liability.

The $25,000 and 75% Rule

Under M.G.L. c. 63, § 38M(d), the research credit is limited to 100% of the first $25,000 of excise (or tax) due, plus 75% of any excise due in excess of $25,000.3 For an individual partner in a PTE, this means their personal income tax liability under Chapter 62 is the baseline for this calculation.1

The Minimum Tax Floor

The credit cannot reduce the tax liability below the minimum excise, which is currently $456 for most corporations.5 For individuals filing Form 1, the credit cannot reduce their tax to zero if they have other tax obligations that cannot be offset by credits, though the R&D credit is generally more flexible for individuals than for corporations regarding the “non-income” measure of the excise.1

Aggregated Group Limitations

When multiple entities are under common control—defined as more than 50% ownership—they are treated as a single taxpayer for purposes of the $25,000 threshold.7 This prevents business owners from splitting their R&D activities into dozens of separate PTEs just to claim multiple $25,000 “full-credit” buckets. The $25,000 limit is prorated among the group members based on their relative tax liabilities.2

The S-Corporation Dichotomy

A frequent point of confusion for practitioners is the treatment of S-corporations. Unlike partnerships, where the QREs flow through to the partners’ K-1s, the Massachusetts R&D credit for an S-corporation is handled exclusively at the entity level.1

Entity-Level Application

S-corporations in Massachusetts are subject to the corporate excise under M.G.L. c. 63, § 39. This excise includes a “non-income measure” based on either the entity’s net worth or its tangible property, and an “income measure” if its total receipts are sufficiently high.2 The S-corporation must apply the R&D credit against this entity-level excise.1

No Flow-Through to Shareholders

Statute and regulation (830 CMR 63.38M.1(3)(e)) explicitly state that the research credit does not flow through to the individual shareholders of an S-corporation.2 If an S-corporation generates a $100,000 credit but only has a $10,000 excise liability, the remaining $90,000 must be carried forward by the S-corporation itself. The shareholders cannot use that $90,000 to offset the tax on their distributive share of the S-corp’s income.1

Carryover Rules: Standard vs. Indefinite

The Massachusetts R&D credit is non-refundable, meaning any credit exceeding the current year’s allowed amount must be carried forward to future years.1

The 15-Year Carryforward

Generally, unused credits can be carried over for 15 taxable years.5 This applies to credits that were not used because the taxpayer was in a loss position or had a total tax liability lower than the credit amount.5

The Indefinite Carryforward Exception

Crucially, any portion of the credit that was disallowed specifically due to the 75% limitation rule (the rule that limits the credit to 75% of the tax over $25,000) can be carried forward indefinitely.1 This is a powerful provision for profitable companies with sustained R&D investments, as it ensures that the “excess” credit is never permanently lost due to high tax liabilities.1

Interaction with the Elective Pass-Through Entity Excise (Chapter 63D)

The most significant change to the PTE landscape in recent years was the 2021 enactment of the Elective Pass-Through Entity (PTE) Excise. This legislation was a direct response to the federal SALT deduction limit of $10,000.19

The SALT Workaround Mechanism

Partnerships and S-corporations can elect to pay a 5% excise on their Massachusetts income at the entity level.11 This excise is deductible for federal tax purposes, which effectively lowers the federal taxable income for the owners.22 The owners then receive a 90% refundable credit on their Massachusetts personal income tax return for their share of the excise paid by the entity.11

Coordination with the R&D Credit

The interaction between the 63D excise and the R&D credit is sequential. On the individual partner’s return (Form 1), the R&D credit is applied first to reduce the personal income tax liability.11 Because the R&D credit is non-refundable, it is prioritized. Once the tax liability is reduced by the R&D credit, the 90% PTE credit is applied. Since the 90% PTE credit is refundable, any amount exceeding the remaining tax liability is paid out to the taxpayer as a cash refund.19

For R&D-heavy partnerships, this creates a “best-of-both-worlds” scenario: the R&D credit wipes out the state tax liability, and the 63D election provides a federal tax deduction and a state cash refund.19

Life Sciences Refundability: The MLSC Exception

While the standard R&D credit is non-refundable, there is a specialized path for “Certified Life Sciences Companies” through the Massachusetts Life Sciences Center (MLSC).1

The Section 38W Credit

Certified life sciences companies may be eligible for a specialized R&D credit under M.G.L. c. 63, § 38W.13 This credit is distinct from the Section 38M credit and requires prior certification from the MLSC.13

90% Refundable Option

A unique feature for life sciences companies is the ability to request a refund of unused research credits.1 If a certified company has an unused 38M credit, it may apply to the MLSC to receive a refund equal to 90% of the value of the credit.9 This provides critical liquidity to pre-revenue biotech firms that are generating significant QREs but have no tax liability to offset.1

Statistical Insights into R&D Tax Expenditures

The Massachusetts research credit represents a major component of the Commonwealth’s tax expenditure budget. The following data, derived from the Governor’s FY25 budget recommendations, illustrates the scale of this incentive.10

The consistent 10% growth rate suggests that despite economic fluctuations, R&D investment remains a priority for Massachusetts businesses. The DOR reports that the bulk of these credits are utilized by companies in the manufacturing, professional services (software), and healthcare sectors.25

Filing Requirements and Documentation

The administrative burden for claiming the R&D credit is significant, particularly for pass-through entities where data must be transmitted across multiple returns.8

Schedule RC and Schedule CMS

All taxpayers claiming the credit must complete Schedule RC (Research Credit) to calculate the amount generated.8 Additionally, Schedule CMS (Credit Manager Schedule) is required to track the “flow” of the credit—showing how much was generated, how much was taken, and how much is being carried forward.27

For a partner in a partnership:

• The partnership issues a Schedule 3K-1 showing the partner’s share of QREs and receipts.30
• The partner completes their own Schedule RC using the 3K-1 data.8
• The partner reports the credit in Section 3 of Schedule CMS (for credits received via K-1).28

Recordkeeping for Audits

The DOR maintains a rigorous audit program for the R&D credit. Pass-through entities must maintain contemporaneous records to support their claims.

• Employee Time Logs: Documents showing the percentage of time each employee spent on qualified research vs. non-qualified activities.1
• Project Descriptions: Narrative summaries of each R&D project, clearly articulating the uncertainty and the process of experimentation.1
• Contractor Agreements: Contracts that specify who retains the “substantial rights” to the research and who bears the “financial risk” of failure.1

Failure to provide these records upon request can lead to the full disallowance of the credit at the partner level.1

Comprehensive Example: “Innovation Partners LLC”

To illustrate the interplay of these rules, consider a hypothetical 2024 scenario involving a Massachusetts partnership and its two owners.

The Entity Profile

Innovation Partners LLC is a software development partnership with two equal partners:

1. Partner A: A Massachusetts resident individual.
2. Partner B: A Massachusetts resident individual.

In 2024, the partnership conducted the following activities:

• Qualified Wages (Cambridge, MA): $800,000.
• Qualified Supplies: $50,000.
• Contract Research (performed in Quincy, MA): $100,000.
• Average QREs (2021-2023): $600,000.
• 2024 Partnership Net Income: $1,200,000 (Allocated $600k to each partner).

Step 1: Attribution of Data

The partnership does not calculate the credit. It reports the following on the Schedule 3K-1 for each partner (50% share) 2:

• Share of 2024 QREs: $450,000 ($400k wages + $25k supplies + $25k contract research [65% of $50k]).
• Share of 3-Year Average QREs: $300,000.

Step 2: Individual Calculation (Partner A)

Partner A elects the Alternative Simplified Method (ASM) on their Schedule RC.3

• Current QREs: $450,000.
• Base Amount (50% of $300k average): $150,000.
• Incremental QREs: $300,000.
• 2024 ASM Credit (10% of $300k): $30,000.

Step 3: Application of Limitations

Partner A’s tax liability on their $600,000 distributive share is $30,000 (assuming a 5% tax rate).5

• First $25,000 of Tax: Offset at 100% = $25,000.3
• Remaining Tax ($5,000): Offset at 75% = $3,750.3
• Total Credit Used: $28,750.
• Tax Payable: $1,250.
• Carryover Generated: $1,250 ($30,000 total – $28,750 used).
• Carryover Type: Indefinite, as it was disallowed by the 75% rule.1

Step 4: The 63D Excise Overlay

If Innovation Partners LLC elected the 63D PTE Excise, it would pay 5% of its $1,200,000 income = $60,000.11

• Partner A receives a refundable credit for 90% of their share = $27,000.11
• Partner A applies the $27,000 credit against their remaining $1,250 tax liability.
• Cash Refund to Partner A: $25,750.19

Conclusion: Strategic Implications for Business Planning

The Massachusetts Research and Development tax credit, when viewed through the lens of pass-through entities, is more than a simple tax break; it is a structural incentive that requires deep integration into a firm’s legal and financial architecture. For partnerships and LLCs, the credit serves as a powerful recruitment and retention tool, effectively lowering the personal tax burden of the owners who are driving the innovation. For S-corporations, the credit acts as a safeguard for the entity’s liquidity, offsetting the unavoidable costs of doing business in the Commonwealth.1

The introduction of the Chapter 63D PTE Excise has fundamentally changed the value proposition of R&D investment for Massachusetts residents. By allowing the R&D credit to essentially “zero out” the state tax liability, business owners can unlock the full value of the refundable PTE credit, creating a direct cash infusion from the state that can be reinvested into new research, additional hiring, or capital expansion.19 As the DOR continues to refine its guidance and as the ASM rates remain at their historic high of 10%, the Massachusetts R&D credit stands as one of the most effective state-level incentives in the United States, provided that taxpayers navigate the complex attribution and limitation rules with precision. Professional peers must emphasize the importance of contemporaneous documentation and proactive entity-level elections to ensure that the “innovation engine” of the Commonwealth continues to be fueled by these substantial tax benefits.1

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/